TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)PRNewsWire • 06/08/21
Transmedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/05/21
TransMedics: Organ Transplant Preservation Technology With Upcoming CatalystsSeeking Alpha • 04/16/21
TransMedics Stock Is Trading Higher After FDA Adcom Votes In Favor Of Its OCS Heart SystemBenzinga • 04/07/21
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart SystemPRNewsWire • 04/06/21
TransMedics Group's (TMDX) CEO Waleed Hassanein on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/03/21
TransMedics to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021PRNewsWire • 02/16/21